Exhibit
12.1









CERTIFICATIONS



I, Dr. Phillip Schwartz, certify
that:



| | 1. | I have reviewed this annual report
                                         on Form 20-F of Entera Bio Ltd.;
| | -- | ------------------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report
                                         does not contain any untrue statement of a material fact or omit to state a material
                                         fact necessary to make the statements made, in light of the circumstances under which
                                         such statements were made, not misleading with respect to the period covered by this
                                         report;
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. | [Reserved]
| | -- | ----------



| | 4. | The company’s other certifying
                                         officer(s) and I are responsible for establishing and maintaining disclosure controls
                                         and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company
                                         and have:
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (a) | Designed such disclosure controls
                                         and procedures, or caused such disclosure controls and procedures to be designed under
                                         our supervision, to ensure that material information relating to the company, including
                                         its consolidated subsidiaries, is made known to us by others within those entities, particularly
                                         during the period in which this report is being prepared;
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (b) | [Reserved]
| | --- | ----------



| | (c) | Evaluated the effectiveness of
                                         the company’s disclosure controls and procedures and presented in this report our
                                         conclusions about the effectiveness of the disclosure controls and procedures, as of
                                         the end of the period covered by this report based on such evaluation; and
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (d) | Disclosed in this report any
                                         change in the company’s internal control over financial reporting that occurred
                                         during the period covered by the annual report that has materially affected, or is reasonably
                                         likely to materially affect, the company’s internal control over financial reporting;
                                         and
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 5. | The company’s other certifying
                                         officer(s) and I have disclosed, based on our most recent evaluation of internal control
                                         over financial reporting, to the company’s auditors and the audit committee of
                                         the company’s board of directors (or persons performing the equivalent functions):
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (a) | All significant deficiencies
                                         and material weaknesses in the design or operation of internal control over financial
                                         reporting which are reasonably likely to adversely affect the company’s ability
                                         to record, process, summarize and report financial information; and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (b) | Any fraud, whether or not material,
                                         that involves management or other employees who have a significant role in the company’s
                                         internal control over financial reporting.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|Date: | April
        17, 2019
|----- | ----------------------
|      |                       

|/s/
        Dr. Phillip Schwartz                                         
|-------------------------------------------------------------------------
|Name: Dr. Phillip Schwartz
        Title: Chief Executive
        Officer